Drug search by name

Siltuximab Intravenous and Renal impairment

Result of checking the interaction of drug Siltuximab Intravenous and disease Renal impairment for safety when used together.

Check result:

Siltuximab Intravenous <> Renal impairment

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Based on a population pharmacokinetic analysis using data from clinical trials in patients, no significant difference in siltuximab clearance was observed in patients with preexisting renal impairment (creatinine clearance (CrCl) >=15 mL/min) compared to patients with baseline normal renal function (CrCl)>= 90 mL/min). No initial dosage adjustment is necessary for patients with CrCl >= 15 mL/min. Care should be taken when using this agent in patients with end-stage renal disease as the potential effect on siltuximab pharmacokinetics cannot be determined. Clinical monitoring of renal function is recommended.

Siltuximab Intravenous

Generic Name: siltuximab

Brand Name: Sylvant

Synonyms: Siltuximab

What is Siltuximab Intravenous?